+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID07351669

Evaluating Spectral CT to Assess Treatment Response After TACE in Liver Cancer

Led by Zhongda Hospital · Updated on 2026-06-10

121

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What this Trial Is About

By comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.

CONDITIONS

Brief Title

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Research Team

S

Shuhang Zhang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here